Abstract:Objective To investigate the effect of echinacoside (ECH) on liver lipid metabolism in db/db mice and its mechanism.Methods Twenty-one healthy male db/db mice aged 8 weeks and weighing from 40 to 48 g were divided into db/db+ECH group [n =11,ECH,300 mg/(kg·d)] and db/db group (n =10,given the corresponding volume of saline) by random number table,db/m mice born with same littermates were served as normal control group,that was db/m group (n =9,given corresponding volume of normal saline).The weight of the mice was measured weekly.The mice were sacrificed 10 weeks after the intervention.The liver tissues were sacrificed and the wet weight of the liver and the weight of the fat around the testes were measured.The total RNA of the liver was extracted and the mRNA of peroxisome proliferator-activated receptor α (PPAR-α) and carnitine palmitoyl transterase-1 (CPT-1) were detected by real-time quantitative PCR.Liver tissue hematoxylin-eosin (HE),oil red 0 staining were used to evaluate pathologic changes.The levels of alanine aminotransferase (ALT),aspartate transaminase (AST),triglyceride (TG),serum total cholesterol (TC),high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C) were measured by automatic biochemical analyzer after fasting for 12 hours and 1 d before the rats were sacrificed.Results Compared with db/m group,the body weight,wet weight of liver and testicular fat around the weight in the db/db group were increased,and the levels of ALT,AST,TG,TC,LDL-C in serum were increased and HDL-C in serum was decreased (P ＜ 0.05 or P ＜ 0.01),liver tissue showed liver cell swelling,vacuolar degeneration,a lot of lipid deposition;ECH intervention could reduce body weight,liver wet weight and testicular fat around the weight of dh/db mice,decrease the levels of ALT,AST,TG,TC,LDL-C and increase the level of HDL-C (P ＜ 0.05 or P ＜ 0.01),improve the pathological changes of liver tissue and lipid deposition,and up-regulate the expression of PPAR-α and CPT-1 in liver tissue (P ＜ 0.05).Conclusion Echinacoside has protective effect on liver of db/db mice,and its mechanism may be related to up-regulating the expression of PPAR-α and CPT-1 in liver tissue and improving lipid metabolism.

Echinacoside Exerts Antihepatic Fibrosis Effects in High-Fat Mice Model by Modulating the ACVR2A-Smad Pathway

Ganoderic Acid A Ameliorates Non-Alcoholic Streatohepatitis (NASH) Induced by High-Fat High-Cholesterol Diet in Mice

Liver Fibrosis Therapy Based on Biomimetic Nanoparticles Which Deplete Activated Hepatic Stellate Cells.

Eggshell Membrane Ameliorates Hepatic Fibrogenesis in Human C3A Cells and Rats Through Changes in PPARγ-Endothelin 1 Signaling.

Effects of echinacoside on liver lipid metabolism in db/db mice

Prevention of Cistanche Salsa Extract on Hepatic Fibrosis Induced by Carbon Tetrachloride in Rats

Effect of Alendronate Sodium on the Expression of Mesenchymal-Epithelial Transition Markers in Mice with Liver Fibrosis

Effect of Echinacoside on Lipid Metabolism in Type 2 Diabetic Mice

Echinacoside improves diabetic liver injury by regulating the AMPK/SIRT1 signaling pathway in db/db mice

Echinacoside Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease by Inhibiting Ferroptosis via Nrf2/HMOX1 Pathway

Echinacoside from Cistanche tubulosa ameliorates alcohol‐induced liver injury and oxidative stress by targeting Nrf2

Echinacoside Alleviates Carbon Tetrachloride‐Induced Chronic Liver Injury by Modulating the NF‐κB/NLRP3 Inflammasome Pathway

Emodin Alleviates Liver Fibrosis of Mice by Reducing Infiltration of Gr1(hi) Monocytes

Echinacoside exerts anti-tumor activity via the miR-503-3p/TGF-β1/Smad aixs in liver cancer

Euryachincoside, a novel phenolic glycoside with anti-hepatic fibrosis activity from Eurya chinensis

Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity

Anti-inflammatory effect of echinacoside in collagen-induced arthritis via Nrf2/Drp1 pathway

Echinatin attenuates acute lung injury and inflammatory responses via TAK1-MAPK/NF-κB and Keap1-Nrf2-HO-1 signaling pathways in macrophages

Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells

Ex-vivo expanded CD34+ cell transplantation alleviates fibrotic liver injury via innate immune modulation in metabolic dysfunction-associated steatohepatitis mice

Immunobiotic Bacteria Attenuate Hepatic Fibrosis through the Modulation of Gut Microbiota and the Activation of Aryl-Hydrocarbon Receptors Pathway in Non-Alcoholic Steatohepatitis Mice